These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38496466)

  • 1. Blocking Src-PSD-95 interaction rescues glutamatergic signaling dysregulation in schizophrenia.
    Featherstone RE; Li H; Sengar A; Borgmann-Winter KE; Melnychenko O; Crown LM; Gifford RL; Amirfathi F; Banerjee A; Parekh K; Heller M; Zhang W; Marc AD; Salter MW; Siegel SJ; Hahn CG
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia.
    Banerjee A; Wang HY; Borgmann-Winter KE; MacDonald ML; Kaprielian H; Stucky A; Kvasic J; Egbujo C; Ray R; Talbot K; Hemby SE; Siegel SJ; Arnold SE; Sleiman P; Chang X; Hakonarson H; Gur RE; Hahn CG
    Mol Psychiatry; 2015 Sep; 20(9):1091-100. PubMed ID: 25330739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex.
    Kalia LV; Pitcher GM; Pelkey KA; Salter MW
    EMBO J; 2006 Oct; 25(20):4971-82. PubMed ID: 16990796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src deficient mice demonstrate behavioral and electrophysiological alterations relevant to psychiatric and developmental disease.
    Ward KR; Featherstone RE; Naschek MJ; Melnychenko O; Banerjee A; Yi J; Gifford RL; Borgmann-Winter KE; Salter MW; Hahn CG; Siegel SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():84-92. PubMed ID: 30826459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.
    Pitcher GM; Kalia LV; Ng D; Goodfellow NM; Yee KT; Lambe EK; Salter MW
    Nat Med; 2011 Apr; 17(4):470-8. PubMed ID: 21441918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine-induced neuroplasticity counteracts the effect of schizophrenia-linked neuregulin 1 signaling on NMDAR function in the rat hippocampus.
    Yamazaki Y; Sumikawa K
    Neuropharmacology; 2017 Feb; 113(Pt A):386-395. PubMed ID: 27784625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src Kinases Regulate Glutamatergic Input to Hypothalamic Presympathetic Neurons and Sympathetic Outflow in Hypertension.
    Qiao X; Zhou JJ; Li DP; Pan HL
    Hypertension; 2017 Jan; 69(1):154-162. PubMed ID: 27802416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia.
    de Bartolomeis A; Vellucci L; De Simone G; Mazza B; Barone A; Ciccarelli M
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postsynaptic Density-95 Isoform Abnormalities in Schizophrenia.
    Funk AJ; Mielnik CA; Koene R; Newburn E; Ramsey AJ; Lipska BK; McCullumsmith RE
    Schizophr Bull; 2017 Jul; 43(4):891-899. PubMed ID: 28126896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The upregulation of NR2A-containing N-methyl-D-aspartate receptor function by tyrosine phosphorylation of postsynaptic density 95 via facilitating Src/proline-rich tyrosine kinase 2 activation.
    Zhao C; Du CP; Peng Y; Xu Z; Sun CC; Liu Y; Hou XY
    Mol Neurobiol; 2015 Apr; 51(2):500-11. PubMed ID: 24981431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The postsynaptic density protein PSD-95 differentially regulates insulin- and Src-mediated current modulation of mouse NMDA receptors expressed in Xenopus oocytes.
    Liao GY; Kreitzer MA; Sweetman BJ; Leonard JP
    J Neurochem; 2000 Jul; 75(1):282-7. PubMed ID: 10854272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting pro-death NMDA receptor signaling dependent on the NR2 PDZ ligand may not affect synaptic function or synaptic NMDA receptor signaling to gene expression.
    Martel MA; Soriano FX; Baxter P; Rickman C; Duncan R; Wyllie DJ; Hardingham GE
    Channels (Austin); 2009; 3(1):12-5. PubMed ID: 19221512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors.
    Cui H; Hayashi A; Sun HS; Belmares MP; Cobey C; Phan T; Schweizer J; Salter MW; Wang YT; Tasker RA; Garman D; Rabinowitz J; Lu PS; Tymianski M
    J Neurosci; 2007 Sep; 27(37):9901-15. PubMed ID: 17855605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
    Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
    Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum.
    de Bartolomeis A; Errico F; Aceto G; Tomasetti C; Usiello A; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():35-43. PubMed ID: 25979765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDARs Adapt to Neurotoxic HIV Protein Tat Downstream of a GluN2A-Ubiquitin Ligase Signaling Pathway.
    Green MV; Thayer SA
    J Neurosci; 2016 Dec; 36(50):12640-12649. PubMed ID: 27810933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src.
    Macdonald DS; Weerapura M; Beazely MA; Martin L; Czerwinski W; Roder JC; Orser BA; MacDonald JF
    J Neurosci; 2005 Dec; 25(49):11374-84. PubMed ID: 16339032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src inhibition reduces NR2B surface expression and synaptic plasticity in the amygdala.
    Sinai L; Duffy S; Roder JC
    Learn Mem; 2010 Aug; 17(8):364-71. PubMed ID: 20660101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of N-methyl-D-aspartic acid (NMDA) receptor subtype-specific binding sites that mediate direct interactions with scaffold protein PSD-95.
    Cousins SL; Stephenson FA
    J Biol Chem; 2012 Apr; 287(16):13465-76. PubMed ID: 22375001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src and Fyn regulation of NMDA receptors in health and disease.
    Rajani V; Sengar AS; Salter MW
    Neuropharmacology; 2021 Aug; 193():108615. PubMed ID: 34051267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.